The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury
Open accessAbstract
Acute kidney injury (AKI) caused by sepsis is a serious disease which mitochondrial oxidative stress and inflammatory play a key role in its pathophysiology.Ceria nanoparticles hold strong and recyclable reactive oxygen species (ROS)-scavenging activity, have been applied to treat ROS-related diseases.However, ceria nanoparticles can't selectively target mitochondria and the ultra-small ceria nanoparticles are easily agglomerated.To overcome these shortcomings and improve therapeutic efficiency, we designed an ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury.Methods: Ceria nanoparticles were modified with triphenylphosphine (TCeria NPs), followed by coating with ROS-responsive organic polymer (mPEG-TK-PLGA) and loaded atorvastatin (Atv/PTP-TCeria NPs).The physicochemical properties, in vitro drug release profiles, mitochondria-targeting ability, in vitro antioxidant, anti-apoptotic activity and in vivo treatment efficacy of Atv/PTP-TCeria NPs were examined.Results: Atv/PTP-TCeria NPs could accumulate in kidneys and hold a great ability to ROS-responsively release drug and TCeria NPs could target mitochondria to eliminate excessive ROS.In vitro study suggested Atv/PTP-TCeria NPs exhibited superior antioxidant and anti-apoptotic activity.In vivo study showed that Atv/PTP-TCeria NPs effectively decreased oxidative stress and inflammatory, could protect the mitochondrial structure, reduced apoptosis of tubular cell and tubular necrosis in the sepsis-induced AKI mice model.Conclusions: This ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin has favorable potentials in the sepsis-induced AKI therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
Zorov, D. B., Juhaszova, M., & Sollott, S. J. (2014) · Physiological Reviews · doi:10.1152/physrev.00026.2013 · Cited by 5,383
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
Wu, J., Wang, X., Wang, Q., Lou, Z., Li, S., Zhu, Y., Qin, L., & Wei, H. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00457a · Cited by 4,108
Self-citationNanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
Wei, H., & Wang, E. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35486e · Cited by 3,779
Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles
Korsvik, C., Patil, S., Seal, S., & Self, W. T. (2007) · Chemical Communications · doi:10.1039/b615134e · Cited by 1,278
Mitochondrial dynamics and apoptosis
Suen, D.-F., Norris, K. L., & Youle, R. J. (2008) · Genes & Development · doi:10.1101/gad.1658508 · Cited by 1,270 · cited 1×
“Mitochondria morphology change is an early sign of ROS-induced mitochondrial dysfunction [52].”
BackgroundNanoceria exhibit redox state-dependent catalase mimetic activity
Pirmohamed, T., Dowding, J. M., Singh, S., Wasserman, B., Heckert, E., Karakoti, A. S., King, J. E. S., Seal, S., & Self, W. T. (2010) · Chemical Communications · doi:10.1039/b922024k · Cited by 1,214
Pharmacological potential of cerium oxide nanoparticles
Celardo, I., Pedersen, J. Z., Traversa, E., & Ghibelli, L. (2011) · Nanoscale · doi:10.1039/c0nr00875c · Cited by 1,151
The definition of acute kidney injury and its use in practice
Thomas, M. E., Blaine, C., Dawnay, A., Devonald, M. A. J., Ftouh, S., Laing, C., Latchem, S., Lewington, A., Milford, D. V., & Ostermann, M. (2015) · Kidney International · doi:10.1038/ki.2014.328 · Cited by 722
Mitochondria-Targeting Ceria Nanoparticles as Antioxidants for Alzheimer’s Disease
Kwon, H. J., Cha, M.-Y., Kim, D., Kim, D. K., Soh, M., Shin, K., Hyeon, T., & Mook-Jung, I. (2016) · ACS Nano · doi:10.1021/acsnano.5b08045 · Cited by 655
Targeting lipophilic cations to mitochondria
Murphy, M. P. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.03.029 · Cited by 598
Ceria Nanoparticles that can Protect against Ischemic Stroke
Kim, C. K., Kim, T., Choi, I., Soh, M., Kim, D., Kim, Y., Jang, H., Yang, H., Kim, J. Y., Park, H., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203780 · Cited by 585
Animal models of sepsis and sepsis-induced kidney injury
Doi, K., Leelahavanichkul, A., Yuen, P. S. T., & Star, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39421 · Cited by 580
Toxicity of Cerium Oxide Nanoparticles in Human Lung Cancer Cells
Lin, W., Huang, Y.-W., Zhou, X.-D., & Ma, Y. (2006) · International Journal of Toxicology · doi:10.1080/10915810600959543 · Cited by 537
Forming Biocompatible and Nonaggregated Nanocrystals in Water Using Amphiphilic Polymers
Yu, W. W., Chang, E., Falkner, J. C., Zhang, J., Al-Somali, A. M., Sayes, C. M., Johns, J., Drezek, R., & Colvin, V. L. (2007) · Journal of the American Chemical Society · doi:10.1021/ja067184n · Cited by 521
Targeting kidney mesangium by nanoparticles of defined size
Choi, C. H. J., Zuckerman, J. E., Webster, P., & Davis, M. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103573108 · Cited by 502
Mitochondria‐targeted antioxidants
Oyewole, A. O., & Birch‐Machin, M. A. (2015) · The FASEB Journal · doi:10.1096/fj.15-275404 · Cited by 464
DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury
Jiang, D., Ge, Z., Im, H.-J., England, C. G., Ni, D., Hou, J., Zhang, L., Kutyreff, C. J., Yan, Y., Liu, Y., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0317-8 · Cited by 447
Paradigms of acute kidney injury in the intensive care setting
Kellum, J. A., & Prowle, J. R. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.184 · Cited by 419
Journal of Polymer Science Part A-1: Polymer Chemistry
(2013) · Journal of Polymer Science Part A-1 Polymer Chemistry · doi:10.1002/(issn)1542-9350 · Cited by 414
Bao, Q., Hu, P., Xu, Y., Cheng, T., Wei, C., Pan, L., & Shi, J. (2018) · ACS Nano · doi:10.1021/acsnano.8b01994 · Cited by 392
Bellomo, R., Kellum, J. A., & Ronco, C. (2007) · Intensive Care Medicine · doi:10.1007/s00134-006-0478-x · Cited by 389
Ceria–Zirconia Nanoparticles as an Enhanced Multi‐Antioxidant for Sepsis Treatment
Soh, M., Kang, D., Jeong, H., Kim, D., Kim, D. Y., Yang, W., Song, C., Baik, S., Choi, I., Ki, S., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201704904 · Cited by 367
Molybdenum-based nanoclusters act as antioxidants and ameliorate acute kidney injury in mice
Ni, D., Jiang, D., Kutyreff, C. J., Lai, J., Yan, Y., Barnhart, T. E., Yu, B., Im, H.-J., Kang, L., Cho, S. Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07890-8 · Cited by 313
Yuan, Y., Liu, J., & Liu, B. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402189 · Cited by 302
Mitochondria in Sepsis-Induced AKI
Sun, J., Zhang, J., Tian, J., Virzì, G. M., Digvijay, K., Cueto, L., Yin, Y., Rosner, M. H., & Ronco, C. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018111126 · Cited by 257
Ceria Nanoparticles Meet Hepatic Ischemia‐Reperfusion Injury: The Perfect Imperfection
Ni, D., Wei, H., Chen, W., Bao, Q., Rosenkrans, Z. T., Barnhart, T. E., Ferreira, C. A., Wang, Y., Yao, H., Sun, T., et al. (2019) · Advanced Materials · doi:10.1002/adma.201902956 · Cited by 251
Surface ligands in synthesis, modification, assembly and biomedical applications of nanoparticles
Ling, D., Hackett, M. J., & Hyeon, T. (2014) · Nano Today · doi:10.1016/j.nantod.2014.06.005 · Cited by 228
Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects.
Yasuda, H., Yuen, P. S. T., Hu, X., Zhou, H., & Star, R. A. (2006) · Kidney International · doi:10.1038/sj.ki.5000300 · Cited by 209
Xu, C., Chang, A., Hack, B. K., Eadon, M. T., Alper, S. L., & Cunningham, P. N. (2014) · Kidney International · doi:10.1038/ki.2013.286 · Cited by 207
Yue, C., Zhang, C., Alfranca, G., Yang, Y., Jiang, X., Yang, Y., Pan, F., Fuente, J. M. D. L., & Cui, D. (2016) · Theranostics · doi:10.7150/thno.14101 · Cited by 184
Defining Acute Renal Failure: RIFLE and Beyond
Van Biesen, W., Vanholder, R., & Lameire, N. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02070606 · Cited by 180
Cytotoxicity and Genotoxicity of Ceria Nanoparticles on Different Cell Lines in Vitro
De Marzi, L., Monaco, A., De Lapuente, J., Ramos, D., Borras, M., Di Gioacchino, M., Santucci, S., & Poma, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14023065 · Cited by 173
Yue, C., Yang, Y., Zhang, C., Alfranca, G., Cheng, S., Ma, L., Liu, Y., Zhi, X., Ni, J., Jiang, W., et al. (2016) · Theranostics · doi:10.7150/thno.15433 · Cited by 169
Liu, D., Jin, F., Shu, G., Xu, X., Qi, J., Kang, X., Yu, H., Lu, K., Jiang, S., Han, F., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.04.034 · Cited by 169
Self-citationSelective iNOS inhibition for the treatment of sepsis-induced acute kidney injury
Heemskerk, S., Masereeuw, R., Russel, F. G. M., & Pickkers, P. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.155 · Cited by 159
Yu, H., Lin, T., Chen, W., Cao, W., Zhang, C., Wang, T., Ding, M., Zhao, S., Wei, H., Guo, H., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119368 · Cited by 128
Self-citationSun, C., Cao, Z., Zhang, X., Sun, R., Yu, C., & Yang, X. (2018) · Theranostics · doi:10.7150/thno.24015 · Cited by 113
Kidney histopathology in lethal human sepsis
Aslan, A., van den Heuvel, M. C., Stegeman, C. A., Popa, E. R., Leliveld, A. M., Molema, G., Zijlstra, J. G., Moser, J., & van Meurs, M. (2018) · Critical Care · doi:10.1186/s13054-018-2287-3 · Cited by 109
Lee, S., Lee, Y.-S., Choi, H., Ko, Y. S., Lee, H., Jo, S.-K., Cho, W.-Y., & Kim, H. K. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825b912d · Cited by 106
Clinical Approach to the Patient With AKI and Sepsis
Godin, M., Murray, P. T., & Mehta, R. L. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.01.003 · Cited by 102
Wang, G., Li, Q., Chen, D., Wu, B., Wu, Y., Tong, W., & Huang, P. (2019) · Theranostics · doi:10.7150/thno.37538 · Cited by 96
Zhou, F., Feng, B., Wang, T., Wang, D., Cui, Z., Wang, S., Ding, C., Zhang, Z., Liu, J., Yu, H., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201703674 · Cited by 89
Self-citationLin, T., Cheng, C.-H., Chen, S., Liou, C., Huang, C., & Chuang, Y. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13078722 · Cited by 72
Manne, N. D. P. K., Arvapalli, R., Nepal, N., Shokuhfar, T., Rice, K. M., Asano, S., & Blough, E. R. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0135-z · Cited by 69
Ceria Nanoparticles that can Protect against Ischemic Stroke
Kim, C. K., Kim, T., Choi, I., Soh, M., Kim, D., Kim, Y., Jang, H., Yang, H., Kim, J. Y., Park, H., et al. (2012) · Angewandte Chemie · doi:10.1002/ange.201203780 · Cited by 61
Yuan, Y., Liu, J., & Liu, B. (2014) · Angewandte Chemie · doi:10.1002/ange.201402189 · Cited by 48
A new biosafe reactive oxygen species (ROS)-responsive nanoplatform for drug delivery
Li, Q., Wen, Y., Wen, J., Zhang, Y., Xu, X., Victorious, A. P., Zavitz, R., & Xu, X. (2016) · RSC Advances · doi:10.1039/c5ra25913d · Cited by 47
Xue, Y., Balmuri, S. R., Patel, A., Sant, V. P., & Sant, S. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0396-1 · Cited by 44
Shielding Therapeutic Drug Carriers from the Mononuclear Phagocyte System: A Review
Sathyamoorthy, N., & Dhanaraju, M. D. (2016) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2016012303 · Cited by 30
Wang, X., Zhang, T., Hu, L., Sun, S., Zhang, W., Sun, Z., Shen, L., & He, B. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6282486 · Cited by 27
Self-citationCho, S. O., Lim, J. W., & Kim, H. (2019) · Free Radical Research · doi:10.1080/10715762.2019.1655145 · Cited by 15
Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects
Lee, H. T. (2007) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/s1073-5437(08)70128-1 · Cited by 11
Cited by
Zhao, M., Wang, Y., Li, L., Liu, S., Wang, C., Yuan, Y., Yang, G., Chen, Y., Cheng, J., Lu, Y., et al. (2021) · Theranostics · doi:10.7150/thno.50905 · Cited by 820
Inorganic nanomaterials with rapid clearance for biomedical applications
Wang, X., Zhong, X., Li, J., Liu, Z., & Cheng, L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00461h · Cited by 509
Self-citationAdvances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs
Liu, Y., Liang, Y., Yuhong, J., Xin, P., Han, J. L., Du, Y., Yu, X., Zhu, R., Zhang, M., Chen, W., et al. (2024) · Drug Design, Development and Therapy · doi:10.2147/dddt.s447496 · Cited by 365
Self-citationNanoscale zeolitic imidazolate framework-8 activator of canonical MAPK signaling for bone repair
Gao, X., Xue, Y., Zhu, Z., Chen, J., Liu, Y., Cheng, X., Zhang, X., Wang, J., Pei, X., & Wan, Q. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c15945 · Cited by 127
Nakamura, T., Sato, Y., Yamada, Y., Abd Elwakil, M. M., Kimura, S., Younis, M. A., & Harashima, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114417 · Cited by 121
Metadata
- Authors
- Yu, H., Jin, F., Liu, D., Shu, G., Wang, X., Qi, J., Sun, M., Yang, P., Jiang, S., Ying, X., & Du, Y.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2020
- Volume
- 10
- Issue
- 5
- Pages
- 2342-2357
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W3003209420
- Cited by
- 364
- References
- 52
- FWCI
- 10.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.